Table 3 Multivariate analyses of factors associated with recurrence-free survival and overall survival
From: ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma
| Â | Hazard ratio (95% CI) | P |
|---|---|---|
RFS | ||
 Tumor size, cm (≥5 vs. <5) | 2.530 (1.355–4.725) | 0.004 |
 ASPP2 (high vs. low) | 0.505 (0.257–0.989) | 0.026 |
 HMGCR (high vs. low) | 2.182 (1.147–4.150) | 0.017 |
OS | ||
 Tumor size, cm (≥5 vs. <5) | 2.103 (1.122–3.942) | 0.02 |
 ASPP2 (high vs. low) | 0.453 (0.235–0.873) | 0.017 |
 HMGCR (high vs. low) | 2.530 (1.355–4.725) | 0.004 |